129 related articles for article (PubMed ID: 19915449)
1. Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp.
Fierro MT; Marenco F; Novelli M; Fava P; Quaglino P; Bernengo MG
Am J Dermatopathol; 2010 Feb; 32(1):91-4. PubMed ID: 19915449
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features of early lesions of primary cutaneous follicle center lymphoma, diffuse type: implications for early diagnosis and treatment.
Gulia A; Saggini A; Wiesner T; Fink-Puches R; Argenyi Z; Ferrara G; Müller CS; Vale E; Cerroni L
J Am Acad Dermatol; 2011 Nov; 65(5):991-1000. PubMed ID: 21704419
[TBL] [Abstract][Full Text] [Related]
3. [Febrile cellulitis surrounding a scar revealing a large immunoblastic B-cell lymphoma].
Charavin-Cocuzza M; Templier I; Simon A; Salameire D; Cuchet E; Reymond JL; Beani JC; Leccia MT
Ann Dermatol Venereol; 2008 Dec; 135(12):848-51. PubMed ID: 19084696
[TBL] [Abstract][Full Text] [Related]
4. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous leiomyosarcoma, trichoblastoma, and syringocystadenoma papilliferum arising from nevus sebaceus.
Premalata CS; Kumar RV; Malathi M; Shenoy AM; Nanjundappa N
Int J Dermatol; 2007 Mar; 46(3):306-8. PubMed ID: 17343592
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous large B-cell non-Hodgkin lymphoma in first-degree relatives.
Čolović M; Vidovic A; Čolović N; Peruničić-Jovanović M; Tomin D
Biomed Pharmacother; 2012 Sep; 66(6):425-7. PubMed ID: 22898082
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous histiocyte and neutrophil-rich CD30+ and CD56+ anaplastic large-cell lymphoma with prominent angioinvasion and nerve involvement in the forehead and scalp of an immunocompetent woman.
Boudova L; Kazakov DV; Jindra P; Sima R; Vanecek T; Kuntscher V; Vera V; Bouda J; Michal M
J Cutan Pathol; 2006 Aug; 33(8):584-9. PubMed ID: 16919035
[TBL] [Abstract][Full Text] [Related]
8. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
[TBL] [Abstract][Full Text] [Related]
9. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
10. [Homogeneous clinical behavior of a group of cutaneous B-cell lymphomas].
de Misa RF; Sastre JL; Azaña JM; Escribano L; Suárez J; Bellas C
Sangre (Barc); 1995 Dec; 40(6):465-70. PubMed ID: 8850229
[TBL] [Abstract][Full Text] [Related]
11. Remarkable remission of a follicular lymphoma treated with rituximab and polychemotherapy (CHOP).
Schmook T; Stockfleth E; Lischner S; Gahn B; Christophers E; Hauschild A
Clin Exp Dermatol; 2003 Jan; 28(1):31-3. PubMed ID: 12558625
[TBL] [Abstract][Full Text] [Related]
12. Uncommon recurrence of follicular lymphoma.
Austein T; Demme B
Eur J Haematol; 2012 Jan; 88(1):91. PubMed ID: 21834796
[No Abstract] [Full Text] [Related]
13. Coincidence of cutaneous follicle center lymphoma and diffuse large B-cell lymphoma.
van Tuyll van Serooskerken AM; Mosterd K; Veraart JC; Vermeer MH; Frank J; van Marion AM
Int J Dermatol; 2008 Nov; 47 Suppl 1():21-4. PubMed ID: 18986480
[TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
15. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
[TBL] [Abstract][Full Text] [Related]
16. [Cutaneous B-cell lymphoma with aggressive clinical presentation: apropos of a case].
Grau E; Real E; Perella M; Escandon J; Pastor E; Gómez A
Sangre (Barc); 1997 Jun; 42(3):231-3. PubMed ID: 9381268
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous follicle center lymphoma responsive to interferon alfa-2a.
Kavala M; Zindanci I; Sudogan S; Can B; Turkoglu Z; Kocaturk E; Koc M; Buyukbabani N
Indian J Dermatol Venereol Leprol; 2011; 77(6):729. PubMed ID: 22016291
[TBL] [Abstract][Full Text] [Related]
18. [Cutaneous B-cell lymphoma treatment with rituximab: two cases].
Viguier M; Bachelez H; Brice P; Rivet J; Dubertret L
Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1152-5. PubMed ID: 12442128
[TBL] [Abstract][Full Text] [Related]
19. [Occurrence of follicular small cleaved cell lymphoma following chemotherapy for diffuse large cell lymphoma].
Saito S; Hayashi K; Ohnoshi T; Kawashima K; Matsutomo S; Tagawa S; Yoshino T; Nishiuchi R; Kimura I
Rinsho Ketsueki; 1994 Jul; 35(7):676-81. PubMed ID: 8065020
[TBL] [Abstract][Full Text] [Related]
20. Solitary plaque on the scalp as a primary manifestation of Hodgkin lymphoma: a case report and review of the literature.
Khalifeh I; Hughey LC; Huang CC; Reddy VV; Sellheyer K
J Cutan Pathol; 2009 Oct; 36 Suppl 1():80-5. PubMed ID: 19775396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
